Meridian Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$483K Sell
13,145
-33,190
-72% -$1.57M 0.02% 526
2025
Q4
$2.36M Buy
46,335
+33,666
+266% +$1.72M 0.08% 208
2025
Q3
$703K Sell
12,669
-2,063
-14% -$121K 0.03% 405
2025
Q2
$1.02M Sell
14,732
-760
-5% -$51.7K 0.04% 306
2025
Q1
$1.08M Sell
15,492
-7,885
-34% -$651K 0.05% 279
2024
Q4
$2.01M Sell
23,377
-103,509
-82% -$11.2M 0.1% 185
2024
Q3
$15.1M Buy
+126,886
New +$16.9M 0.74% 23
2024
Q2
Sell
-96,386
Closed -$12.4M 466
2024
Q1
$12.4M Buy
96,386
+42,385
+78% +$5.05M 2.06% 9
2023
Q4
$5.59M Sell
54,001
-9,921
-16% -$981K 0.36% 63
2023
Q3
$5.81M Buy
63,922
+30,062
+89% +$2.65M 0.36% 54
2023
Q2
$2.74M Buy
33,860
+22,680
+203% +$1.85M 0.23% 95
2023
Q1
$890K Sell
11,180
-174
-2% -$12.3K 0.08% 224
2022
Q4
$768K Buy
11,354
+5,394
+91% +$316K 0.08% 235
2022
Q3
$297K Sell
5,960
-2,510
-30% -$134K 0.03% 370
2022
Q2
$472K Buy
+8,470
New +$470K 0.04% 362
2019
Q3
Sell
-1,820
Closed -$464 385
2019
Q2
$464 Buy
+1,820
New +$45K 0.02% 382

Other funds holding NVO

Meridian Wealth Management's NVO Position: Q1 2026 in Review

Meridian Wealth Management reduced its Novo Nordisk (NVO) stake by 72% in Q1 2026, selling an estimated $1.57M and leaving 13,145 shares worth $483K. The position accounts for 0.02% of the portfolio, ranked #526.

Meridian Wealth Management first reported a position in NVO in Q2 2019 and has held it in 16 quarters since. The position peaked at $15.1M in Q3 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Meridian Wealth Management held 13,145 shares of Novo Nordisk worth $483K as of Q1 2026.
  • Meridian Wealth Management sold 33,190 Novo Nordisk shares in Q1 2026, an estimated $1.57M.
  • Novo Nordisk made up 0.02% of Meridian Wealth Management's portfolio in Q1 2026, its #526 holding.
  • Meridian Wealth Management first reported a position in Novo Nordisk in Q2 2019 and has held it in 16 quarters since.
  • Meridian Wealth Management's Novo Nordisk position peaked at $15.1M in Q3 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Meridian Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.